Chinese names line up to list in Hong Kong

Hang Seng Stock Exchange
By Clare Hammond
14 Feb 2014

Applications from Chinese companies to launch IPOs in Hong Kong are coming thick and fast.

Luye Pharma Group, for example, is planning to conduct a $750m Hong Kong IPO as early as the second quarter, according to a banker close to the deal. 

“The Chinese medical space was one of the hottest sectors last year and we expect that trend to continue at ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.